{
  "report_rows": [
    {
      "kpi": "Comparable RevPAR (Q2 2026)",
      "prediction": "BEAT",
      "answer": "pred ~$252 vs. cons $248.07",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "Comp. Hotel EBITDA Margin (Q2 2026)",
      "prediction": "BEAT",
      "answer": "pred ~32.2% vs. cons 31.58%",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "AFFO per Share (Q2 2026)",
      "prediction": "BEAT",
      "answer": "pred ~$0.64 vs. cons $0.619",
      "confidence": "MEDIUM"
    }
  ],
  "guide_rows": [
    {
      "kpi": "FY 2026 Adj. EBITDAre (FY 2026)",
      "prediction": "BETTER",
      "answer": "guide ~$1,845M midpoint vs. cons $1,813.9M",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "FY 2026 Comp. RevPAR Growth (FY 2026)",
      "prediction": "BETTER",
      "answer": "guide ~4.25% midpoint vs. cons ~3.5% implied",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "H2 2026 RevPAR Tone (H2 2026)",
      "prediction": "UNCHANGED",
      "answer": "guide 'low single digits' maintained with slight upward bias vs. cons ~2-3%",
      "confidence": "HIGH"
    }
  ],
  "day1_residual_pct": -1.0,
  "day1_confidence": "MEDIUM",
  "day5_residual_pct": -2.5,
  "day5_path": "FADE",
  "day5_rationale": "FADE \u2014 beat + raise already priced into +15% run since Q1; H2 language cautious; short-cover provides floor vs. worst A-quarter outcomes",
  "day5_confidence": "MEDIUM"
}